In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

Argent BioPharma is up 65% today after its flagship cannabinoid-based therapy for refractory epilepsy CannEpil was approved ...

In a 24-7 vote, the Texas Senate recently passed Senate Bill 3 to ban hemp products across the state, a change proponents say ...

I’m a small-time drug dealer from the south, says the hypnagogic text hovering before me as I start Schedule 1. It says I’ve ...

Known as the cell’s engine, the mitochondria propels the sperm toward the egg, explained Dr. Houda Amor, a co-author of the ...

Cannabis is more than just a recreational indulgence—it’s a powerhouse of wellness, sustainability, and industry. From hemp’s ...

The Certificates, requested by HYTN in February, are important for drug registrations in jurisdictions where they apply. They ...

Voters may get the opportunity to choose whether Oklahoma becomes the next state to have recreational marijuana, thanks to a ...

Ananda Pharma PLC announced on Wednesday that it had received approval for the phase 1 pharmacokinetic study of its lead investigational cannabidiol drug candidate, MRX1, in Australia. The ...

Trump’s tariffs hit markets hard, wiping billions off the ASX, while gold soars and China and the EU gear up for retaliation.

Trump’s tariffs have hit global exports, with China copping it hardest and Australia facing a 10pc levy. Meanwhile, gold hits record highs.

A controversial bill that would outlaw all THC products in Texas has passed the Senate and is now in the hands of the House, sparking widespread concern among small ...